![]() Aprea Therapeutics ABAprea is developing pharmaceuticals that reactivates the tumor suppressor protein p53, which is impaired in many instances of cancer. www.aprea.com |
![]() Dilafor ABDilafor is dedicated to the development of pharmaceutical products aimed at minimizing the risk for protracted labor and associated complications. www.dilafor.com |
![]() Forendo Pharma OyForendo Pharma develops novel pharmaceutical treatments for endometriosis and for male patients with low testosterone levels. www.forendo.com |
||
![]() Modus Therapeutics ABModus is developing innovative treatments for patients with sickle-cell disease based on a heparin analogue, sevuparin. Sickle-cell disease is a painful, inherited blood disorder affecting millions of people around the globe. www.modustx.com |
OssDsign ABOssDsign is developing pioneering implants for bone healing with an initial focus on skull surgery. www.ossdsign.com |
Promimic ABPromimic develops and markets a nano-based surface applied to dental and bone implants for improved integration to bone and soft tissue www.promimic.com |
||
![]() Umecrine Cognition ABUmecrine Cognition is developing a therapy that represents a new target class for several major CNS-related disorders. www.umecrinecognition.com |
Pharmanest ABPharmanest is specialized in the development of new topical analgesic formulations to be used on the mucosa. www.pharmanest.se |
![]() Asarina Pharma ABAsarina Pharna is developing innovative and targeted products to treat women with disorders associated with the menstrual cycle. www.asarinapharma.com |